OASIS neuropsychiatry
Revolutionizing Mental Health Through Quantum EEG Technology
Company Overview
Snapshot
Founded in June 2025 by Benjamin Soffer, OASIS neuropsychiatry operates with 1–10 employees. The company is currently in its Pre-Funding stage, focusing on developing its quantum EEG technology.
Business overview
OASIS neuropsychiatry is dedicated to transforming mental healthcare through quantum neuroscience. The company's core technology involves advanced quantum EEG to provide real-time insights into brain function, enabling precise measurement of neural activity patterns. This platform supports real-time brain activity monitoring, predictive treatment response algorithms, and personalized therapy recommendations, all backed by rigorous scientific research and clinical validation. OASIS neuropsychiatry serves the healthcare industry, specifically targeting providers within the digital therapeutics and digital healthcare sectors.
Company Intelligence Q&A
- When was OASIS neuropsychiatry founded?
- OASIS neuropsychiatry was founded in June 2025.
- Who is a founder of OASIS neuropsychiatry?
- Benjamin Soffer is a co-founder of OASIS neuropsychiatry.
- What is the primary focus of OASIS neuropsychiatry's technology?
- OASIS neuropsychiatry focuses on quantum EEG technology to provide real-time, personalized neuropsychiatric care by analyzing brain function and neural activity patterns.
- What stage is OASIS neuropsychiatry currently in?
- OASIS neuropsychiatry is currently in the Pre-Funding stage.
- What markets does OASIS neuropsychiatry serve?
- OASIS neuropsychiatry serves the healthcare and life sciences markets, specifically targeting healthcare providers with its digital therapeutics solutions.